Netherlands Focus The company operates primarily in The Netherlands, presenting a targeted regional market opportunity for Life Sciences consulting services covering drug development to GMP-ready manufacturing.

Small to Mid Market With 51-200 employees and revenue under one million, Progress targets small to mid-sized pharma, biotech, and healthcare organizations that may require scalable CQV, CMC, MSAT, and quality systems support.

Full Lifecycle Expertise Offerings span engineering, commissioning and qualification, validation, CMC/MSAT, and QA/QC, enabling cross-functional support for critical development programs and smooth progression to manufacturing milestones.

Accelerate Compliance Position as practical, fast-moving partner to reduce compliance risk and accelerate timelines, appealing to startups and scale-ups needing hands-on expertise without long internal resource commitments.

Growth Partnerships Leverage relationships with global multinationals and local biotech players to expand project-based collaborations, expand service scope, and target opportunities in GMP readiness and manufacturing scale-up.